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Reduction of the bis-pilocarpate-haemin complex at pH ) 10 involves the simultaneous uptake of an 
electron by the Fe(II1) ion and a proton by the pendant alkoxide group of an axial ligand. This provides 
a protein-free model for reactions such as the proton-coupled reduction of cytochromes which involve 
cooperative Coulombic interaction between two non-bonded sites. 
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1. INTRODUCTION 
The use of steric effects by the protein to modify 
and control the activity of the metal in metallo- 
proteins has been elucidated with the help of 
protein-free models in the case of haemoglobin [11 
and the Brz-dependent isomerases [2]. Far less is 
known about the use of Coulombic effects (in- 
cluding hydrogen-bonding), which must be in- 
volved in phenomena ranging from the ion- 
coupled reduction of cytochromes and the activa- 
tion of Hz02 by peroxidases (see [3]) to the ion-de- 
pendent ATPases. Protein-free models are needed 
in which one can study cooperative Coulombic in- 
teraction between two non-bonded sites, involving 
the uptake of a negative charge (electron or anion) 
at one site and a positive charge (proton or cation) 
at the other. 
We have therefore been studying the formation 
and reduction of complexes of Fe(II1) protopor- 
phyrin IX (haemin), in which both axial sites are 
occupied by imidazole derivatives (denoted by B, 
see fig. 1) with side-chains possessing various func- 
tional groups, and have been examining how the 
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Fig.1. Structure of the imidazole derivatives (I-VI) 
mentioned in the text; all are denoted by B in formulae 
and equations. 
I Imidazole R,=H R,=H 
II KMethyliiidazole Me H 
III Histamine H -CH,-CH,-NH; 
IV Histidine H -CH,-YH-NH; 
co; 
V Pilocarpine Me -CH,-CH-CHEt 
>co 
CH,-0 
VI Pilocarpate Me -CH,-YH-CHEt-CO; 
CH,OH 
pK values of such groups are affected by the prox- 
imity of the net charge of + 1 on the Fe(II1) ion 
(with two negative charges on the porphyrin) and 
by subsequent reduction to the Fe(I1) state. The 
Fe(II1) complexes of interest (viz. FeB2, with only 
the axial ligands designated) are formed in aqueous 
solution by reaction of the dimeric (concentrations 
were, however, calculated on the basis of 
monomeric F&H) alkaline form of haemin [4-61 
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(here written (FeOH)z) with B according to 
equilibrium 1 without the intermediate formation 
of any mononuclear monoimidazole complex 
[6,7]; the equilibria cannot be studied below pH 8 
because haemin forms aggregates. We are 
therefore interested primarily in functional groups 
with ‘normal’ pK values above 8, in particular 
-NH2 (as in Lys, Arg) and -OH (Ser, Thr, Tyr). 
(FeOH)2 + 4B = 2FeB2 + 20H- (1) 
We have previously reported that the FeB2 com- 
plex with histidine (IV) undergoes proton-coupled 
reduction and identified the site of proton-uptake 
as a pendant -NH2 group of IV [3]. We now report 
that the complex with pilocarpate (VI) also exhibits 
proton-coupled reduction, which can be ascribed 
to a change in the pK of a pendant -OH group. 
This provides an example of the second type of 
functional group and emphasises the generality of 
the underlying mechanism of cooperative interac- 
tions in proton-coupled reductions. 
2. MATERIALS AND METHODS 
Solutions of haemin (BDH) were prepared by 
dissolution in deoxygenated (N2) 0.1 M NaOH. 
Solutions of VI were prepared by hydrolysing V 
(pilocarpinium nitrate, Merck) in 0.1 M NaOH at 
30°C for 1 h [8]. II (Merck) was used as supplied. 
Buffers (NaHC03 + NaOH, p = 0.3) were 
prepared according to [9]. UV-visible spectra were 
recorded with a JASCO Uvidec-1 spec- 
trophotometer, and pH determined with a 
Metrohm microelectrode model 9100. Unless 
otherwise indicated, all experiments were carried 
out in aqueous solution (pH 8-14) at 25°C. 
3. RESULTS 
3.1. Preliminary experiments 
As a background to experiments on the FeB2 
complex with VI we (a) determined the pK values 
of free VI and (b) studied the complex with the 
simpler ligand II, whose identity has already been 
established [5]. (a) Two 40-ml samples of 0.2 M VI 
in 0.1 M NaOH were titrated with 0.2 M HCl from 
pH 13 to 1.3; both gave pK values of 7.5 and 3.7 
(each corresponding to 1.0 f 0.1 protons), which 
can be assigned to protonation of the imidazole 
(7.5) and carboxylate (3.7) groups, with no detec- 
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table (pK 2 13.5) ionisation of the hydroxyl. This 
also confirms that hydrolysis of the lactone is 
essentially complete. (b) We found no change in 
the wavelength (411 nm) of this complex over the 
whole range of pH 8-14; although equilibrium 1 is 
reversed by high pH, the rate is slow enough for 
the spectra to be recorded. 
3.2. Equilibrium between haemin and pilocarpate 
(VI); ionisation of the Iigand 
Reacting haemin (Soret band at 385 nm) with VI 
revealed two successive and partly overlapping 
equilibria. The first involves minor changes in 
spectrum (decrease in intensity without significant 
shift in the wavelength of the Soret band). Titra- 
tion of 9.05 x 10e5 M haemin solutions at pH 8.5, 
10.0 and 11.0 with VI (up to -2 x 10m2 M) and 
analysis of the changes in A590 (isosbestic point of 
the second equilibrium) agreed with the pH- 
independent formation of an adduct according to 
equilibrium 2 (cf. the analogous adduct with IV 
[3]) and log KZ = 2.0 + 0.2 
(FeOH)2 + B = (FeOH)2 - B 
(FeOH)2 - B + 3B = 2FeB2 + 20H- 
log ([FeB2]/[(FeOH)2B]) = 
(2) 
(3) 
log K3 - 210g [OH-] + 310g [B] (4) 
adOg [&I = 0.5(1 -a) log [FeT] (5) 
The second equilibrium is characterised by the 
appearance of a new Soret band in the 
411-413 nm region, typical of a FeB2 complex [5]. 
Two tests of the expected equilibrium 3 can be 
made. Firstly, the equilibrium constant K3 can be 
rearranged to give eq.4. Titrating a solution of 
7.46 x 10e6 M haemin with up to -5 x 10v2 M at 
pH 10 and plotting the first against he last term in 
eq.4 gives a slope of 3, as expected, and an ap- 
parent value of log K3 = - 8.3. We next keep [B] 
constant but vary FeT] and apply eq.5 (the dilu- 
tion test [8]), where cy is the fraction of the total 
iron present as FeB2; a plot of the first against he 
last term should give a slope of 0.5. Dilution over 
the range of -0.1-3 x lo-’ M Fe gave slopes of 
0.4-0.5 at all pH values, but the values of log K3 
varied with pH as follows: - 9.5, - 9.5 and - 9.7 
(separate experiments) at pH 8.5 with 0.005 M B; 
- 9.0 at pH 9.0 with 0.005 M B; - 8.4 at pH 10.0 
with0.025 MB; -7.4, -7.5 and -7.3 atpH 11.0 
with 0.05 M B. This indicates that the FeBz com- 
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plex can lose one proton with pK = 10.0, as shown 
by the virtually pH-independent values of - 9.6, 
-9.1, - 9.0 and - 9.5 obtained for log Ks at pH 
8.5, 9, 10 and 11 respectively after correcting the 
observed values for the additional formation of the 
deprotonated complex at higher pH. In agreement 
with this, the Soret band shows a small shift from 
411 nm below, to 413 nm above, pH 10. 
3.3. Reduction of the his-pilocarpate-Fe(II) 
complex 
Reducing the complex with NazS204 produces a 
spectrum (maxima at 422,529 and 556 nm) similar 
to that of the Fe(I1) form of cytochrome by (422.5, 
525 and 556 nm [lo]), where both axial ligands are 
known to be His, i.e., the FeB2 core remains un- 
changed. The reversibility and pH-dependence of 
reduction were studied (in 9 separate ex~riments~ 
by cyclic voltammetry under NZ from pH 8 to 11 
using a Pt working electrode with solutions con- 
taining 0.5 x lo-’ M haemin in 0.2 M VI and 
0.1 M NaHCOr , raising the pH by adding 6 M 
NaOH, and using a scan rate of 3 100 mV/s (cf. 
[3]), As shown for one experiment in fig.2, E% is 
virtually pH-independent below pH 9 (El,/ = 
- 0.197 f 0.004 V vs SHE at pH 8) but approaches 
a slope of 59 mV per pH unit (i.e., one proton per 
electron) at pH 2 10.5; the inflection corresponds 
to pl%u = 9.7 f 0.1 in the Fe(II1) complex (strictly 
speaking at the electrode surface, but clearly 
related to the pK of 10.0 observed in solution) and 
~KII > 13 in the Fe(I1) complex. Further ex- 
periments showed that the pH-dependence was 
Fig.2. Plot of I?% (in V YS SHE) against pH for 
reduction of the ~~-pilo~~pate-hail complex. 
Curve calculated with Et; = - 0.197 V at pH 8, p&r = 
9.7 and pK11 > 13 (-), limiting slope of 59 mV/pH 
(---). 
reversible and not significantly affected by chang- 
ing the working electrode (Pt or hanging mercury 
drop) or the supporting electrolyte (Li/Na/KNOJ, 
NaCl) . 
4. DISCUSSION 
Coordination of the imidazole ring of III by the 
Co(II1) ion in cyanoaquocobinamide (net charge 
of f 1) reduces the pK of the pendant -NH2 from 
9.5 (when free) to 4.5 Ill]. Formation of the FeBz 
complex with both III (unpub~sh~) and IV [3] 
also involves the loss of one proton per Fe due to 
a lowering of the pK of a pendant -NH2. Our 
results show that the FeB2 complex with VI, which 
is formed according to eq. 1 at pH 8-10, can ionise 
with pK = 10. This could involve either (a) ionisa- 
tion of a pendant -OH (expected pK - 15 in the 
free ligand 1121) or (b) formation of an ion-pair 
with OH-. The behaviour of coordinated III and 
IV provides a precedent for (a), while failure to 
detect any analogous changes with II (see section 
3.1) militates against (b). We conclude that the 
equilibrium involves ionisation of a pendant -OH 
group. 
We reported previously [3] that the pH- 
dependence of E, for reduction of the bis- 
histidine-Fe(II1) complex corresponds to the 
simultaneous uptake of one proton per electron 
over the whole range of pH 8-10, and we ascribed 
this to the rise in pK of the pendant -NH2 group as 
the residual charge on the Fe(II1) ion was 
eliminated by the uptake of an electron. The bis- 
pilocarpate comple:r provides an opportunity to 
test this theory by exa‘;iGng the pH-dependence 
of Es both above and below %e observed pK of 
the Fe(II1) complex. Fig.2 shows that E1/ is pH- 
independent below pH 9 but approaches a slope 
corresponding to one proton taken up per electron 
above pH 10, in agreement with the proposed 
mechanism. 
The his-histi~ne and his-piloca~ate complexes 
of haemin appear to be the first reported examples 
of proton-coupled reduction in protein-free metal 
complexes where Coulombic interaction provides 
the main or cnly interaction between the site of 
protonation and the metal; they are particularly 
relevant as models for mitochon~i~ cytochrome 
b, which exhibits protoncoupled reduction 
113,141, is implicated in proton translocation 
341 
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[14,15] and probably possesses two His residues as 
axial ligands [16]. Our results support a 
mechanism whereby (i) the presence of a residual 
positive charge on the metal can significantly lower 
the pK of a neigh~uri~ group by stabilising a 
negatively charged conjugate base (e.g., -O-) or 
destabilising a positively charged conjugate acid 
(e.g., -NH$); and (ii) the subsequent uptake of an 
electron by the metal can be coupled with the 
simultaneous ptake of a proton by the neighbour- 
ing functional group as the Coulombic interaction 
is reduced and the pK rises towards a more normal 
vahre; with a negatively charged core (as in fer- 
redoxins and rubredoxins) the relevant pK would, 
of course, be more normal when the metal is ox- 
idised and abnormally high when the metal is 
reduced. 
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